BIOMARIN PHARMACEUTICAL INC Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2018-04-27: Form 10-Q; Exhibit 10.1; Description First Amendment to Credit Agreement dated as of March 15, 2018, by and among BioMarin Pharmaceutical Inc., the lenders party thereto, and Bank of America, N.A. as Administrative Agent..
- 2018-02-26: Form 10-K; Exhibit 10.47; Description Asset Purchase Agreement by and between Novartis Pharma AG, BioMarin Pharmaceutical Inc. and BioMarin Commercial Ltd., dated as of November 21, 2017..
| Filed | Form | Exhibit | Description |
|---|
| 2018-04-27 | 10-Q | 10.1 | First Amendment to Credit Agreement dated as of March 15, 2018, by and among BioMarin Pharmaceutical Inc., the lenders party thereto, and Bank of America, N.A. as Administrative Agent. |
|---|
| 2018-02-26 | 10-K | 10.47 | Asset Purchase Agreement by and between Novartis Pharma AG, BioMarin Pharmaceutical Inc. and BioMarin Commercial Ltd., dated as of November 21, 2017. |
|---|